chartexchange

CLGN
CollPlant Biotechnologies Ltd
stockNASDAQ

At CloseNov 12, 2026
4.64USD+17.172%(+0.68)439,303
Loading…
Loading…
Healthcare
Biotechnology
CEO
Yehiel Tal
HQ
Rehovot, Rehovot, Israel
Previous Close
$3.96
Beta
-0.38
52-Week High
$22.50 2025-11-28
52-Week Low
$2.64 2026-08-28
SMA 50
$3.84
SMA 200
$4.54
Avg. Vol 10D
78,407
Avg. Vol 30D
59,844
Avg. Vol 90D
269,266
Relative Vol
7.34
864,516
38.3400%
4,000
Sep 4, 2026 · 1-for-10 (reverse)
CLGN Profile

collplant is a regenerative medicine company focused on 3d bioprinting of tissues and organs, and on developing and commercializing tissue repair products for orthobiologics, and advanced wound care markets. our products are based on our rhcollagen (recombinant human collagen) that is produced with collplant's proprietary plant based genetic engineering technology. our products address indications for diverse fields of organ and tissue repair, and are ushering in a new era in regenerative medicine. our flagship rhcollagen bioink product line is ideal for 3d bioprinting of tissues and organs, and our unique vergenix line of rhcollagen products includes a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. collplant is a public company listed on the tel aviv stock exchange and on nasdaq (clgn).

CLGN Performance
PeriodPriceDateChangeBeta
1W3.962026-11-11+17.17%0.000
1M3.562026-10-19+30.34%-0.519
3M3.142026-08-18+47.58%0.025
6M4.352026-05-18+6.72%-0.075
1Y21.502025-11-18-78.42%-0.384
2Y41.502024-11-18-88.82%—
5Y186.502021-11-18-97.51%0.037
CLGN Stock Summary

CollPlant Biotechnologies Ltd (NASDAQ:CLGN) stock price today is $4.64, and today's volume is 439,303. The 30 day average volume is 59,844. CLGN market cap is $14.27M with 3.08M shares outstanding.